The medical needle free injection market size has grown rapidly in recent years. It will grow from $16.13 billion in 2025 to $18.19 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising vaccination programs, concerns over needle-stick injuries, growth in outpatient care settings, increasing acceptance of non-invasive therapies.
The medical needle free injection market size is expected to see rapid growth in the next few years. It will grow to $29.21 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in advanced drug delivery platforms, rising demand for self-administered therapies, expansion of biologics and vaccines pipeline, growing focus on patient-centric medical devices, technological advancements in microfluidic injection systems. Major trends in the forecast period include increasing adoption of painless drug delivery systems, rising demand for needle-free vaccination technologies, growing integration of electronically controlled injection devices, expansion of home-based self-administration solutions, enhanced focus on patient comfort and compliance.
The growing number of diabetes patients is anticipated to drive the expansion of the medical needle-free injection market. Diabetes is a long-term condition where the body struggles to regulate blood glucose levels effectively. The increasing prevalence of diabetes is primarily linked to the rising incidence of obesity, a major risk factor for type 2 diabetes. Needle-free injection systems offer a painless, non-invasive method for administering insulin or other medications using high-pressure technology. These systems reduce pain, ease needle-related anxiety, and improve patient compliance with treatment regimens. For example, according to a June 2024 report from the National Health Service (NHS), a UK-based government agency, 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023 - an 18% increase from 3,065,825 cases in 2022. This rising number of diabetes cases is contributing to the growth of the medical needle-free injection market.
Key players in the medical needle-free injection market are focusing on technological innovations such as jet-based injection systems to enhance drug delivery and increase patient comfort. These systems use high-pressure liquid streams to deliver medication without needles, providing a safer and more comfortable alternative to traditional injections. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical device manufacturer, introduced the InsuJet needle-free insulin injector in Canada. The device employs high-pressure jet technology to administer insulin without needles, aiming to decrease pain, reduce anxiety, and minimize needle-associated risks, thereby promoting better adherence to treatment.
In May 2024, Serum Institute of India (SII), an India-based biotechnology company, acquired a 20% stake in IntegriMedical for an undisclosed sum. The acquisition is intended to combine SII’s vaccine production capabilities with IntegriMedical’s expertise in needle-free injection technology, with the goal of accelerating the development and worldwide distribution of safer and more efficient vaccine delivery methods. This partnership aims to enhance patient comfort and reduce needle-related injuries. IntegriMedical is a US-based biotechnology company that specializes in the development and commercialization of needle-free drug delivery systems.
Major companies operating in the medical needle free injection market are PharmaJet Inc., Portal Instruments Inc., Medical International Technology Inc. (MIT), NuGen Medical Devices Inc., Crossject SA, Bioject Medical Technologies Inc., Antares Pharma Inc., Ferring Pharmaceuticals, Akra Dermojet, PenJet Corporation, Vaxxas Pty Ltd., Micron Biomedical Inc., Injex Pharma AG, Sol‑Millennium Medical Group, LTS Lohmann Therapie‑Systeme, Enable Injections, Comfort‑in, Needle Free India, Glide Pharma, Aijex Pharma, QS Medical Technology, IntegriMedical, NovaXS Biotech.
North America was the largest region in the medical needle free injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical needle free injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical needle free injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical needle free injection market by increasing costs of imported precision components, microfluidic assemblies, electronic control units, and medical-grade plastics used in advanced injector systems. Healthcare device manufacturers in North America and Europe are most affected due to reliance on globally sourced high-precision parts, while Asia-Pacific faces cost pressures in export-oriented manufacturing. These tariffs are increasing device production costs and affecting pricing strategies for hospitals and clinics. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic medical device innovation and assembly capabilities.
The medical needle free injection market research report is one of a series of new reports that provides medical needle free injection market statistics, including medical needle free injection industry global market size, regional shares, competitors with a medical needle free injection market share, detailed medical needle free injection market segments, market trends and opportunities, and any further data you may need to thrive in the medical needle free injection industry. This medical needle free injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical needle-free injection is a device that administers medications or vaccines through the skin using high-pressure technology, eliminating the need for a traditional needle. It works by creating a fine stream of liquid that penetrates the skin, enabling the quick and painless delivery of drugs.
The primary types of medical needle-free injectors include jet-based, spring-based, laser-powered, and vibration-based injectors. Jet-based needle-free injectors use a high-pressure liquid stream to deliver medication through the skin without needles, offering a safer and less painful alternative for administering vaccines and insulin. These injectors can deliver medication in different modes, such as subcutaneous, intramuscular, intradermal (ID), and intravenous (IV), and are used for a variety of applications including vaccine administration, insulin delivery, pain management, oncology treatments, and more. They are utilized by various end-users, including hospitals, clinics, home care settings, research laboratories, and others.
The medical needle-free injection market consists of sales of gas-powered needle-free injectors, electroporation-based injectors, transdermal patch systems, and powder injector systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical needle free injection market size is expected to see rapid growth in the next few years. It will grow to $29.21 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in advanced drug delivery platforms, rising demand for self-administered therapies, expansion of biologics and vaccines pipeline, growing focus on patient-centric medical devices, technological advancements in microfluidic injection systems. Major trends in the forecast period include increasing adoption of painless drug delivery systems, rising demand for needle-free vaccination technologies, growing integration of electronically controlled injection devices, expansion of home-based self-administration solutions, enhanced focus on patient comfort and compliance.
The growing number of diabetes patients is anticipated to drive the expansion of the medical needle-free injection market. Diabetes is a long-term condition where the body struggles to regulate blood glucose levels effectively. The increasing prevalence of diabetes is primarily linked to the rising incidence of obesity, a major risk factor for type 2 diabetes. Needle-free injection systems offer a painless, non-invasive method for administering insulin or other medications using high-pressure technology. These systems reduce pain, ease needle-related anxiety, and improve patient compliance with treatment regimens. For example, according to a June 2024 report from the National Health Service (NHS), a UK-based government agency, 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023 - an 18% increase from 3,065,825 cases in 2022. This rising number of diabetes cases is contributing to the growth of the medical needle-free injection market.
Key players in the medical needle-free injection market are focusing on technological innovations such as jet-based injection systems to enhance drug delivery and increase patient comfort. These systems use high-pressure liquid streams to deliver medication without needles, providing a safer and more comfortable alternative to traditional injections. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical device manufacturer, introduced the InsuJet needle-free insulin injector in Canada. The device employs high-pressure jet technology to administer insulin without needles, aiming to decrease pain, reduce anxiety, and minimize needle-associated risks, thereby promoting better adherence to treatment.
In May 2024, Serum Institute of India (SII), an India-based biotechnology company, acquired a 20% stake in IntegriMedical for an undisclosed sum. The acquisition is intended to combine SII’s vaccine production capabilities with IntegriMedical’s expertise in needle-free injection technology, with the goal of accelerating the development and worldwide distribution of safer and more efficient vaccine delivery methods. This partnership aims to enhance patient comfort and reduce needle-related injuries. IntegriMedical is a US-based biotechnology company that specializes in the development and commercialization of needle-free drug delivery systems.
Major companies operating in the medical needle free injection market are PharmaJet Inc., Portal Instruments Inc., Medical International Technology Inc. (MIT), NuGen Medical Devices Inc., Crossject SA, Bioject Medical Technologies Inc., Antares Pharma Inc., Ferring Pharmaceuticals, Akra Dermojet, PenJet Corporation, Vaxxas Pty Ltd., Micron Biomedical Inc., Injex Pharma AG, Sol‑Millennium Medical Group, LTS Lohmann Therapie‑Systeme, Enable Injections, Comfort‑in, Needle Free India, Glide Pharma, Aijex Pharma, QS Medical Technology, IntegriMedical, NovaXS Biotech.
North America was the largest region in the medical needle free injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical needle free injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical needle free injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical needle free injection market by increasing costs of imported precision components, microfluidic assemblies, electronic control units, and medical-grade plastics used in advanced injector systems. Healthcare device manufacturers in North America and Europe are most affected due to reliance on globally sourced high-precision parts, while Asia-Pacific faces cost pressures in export-oriented manufacturing. These tariffs are increasing device production costs and affecting pricing strategies for hospitals and clinics. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic medical device innovation and assembly capabilities.
The medical needle free injection market research report is one of a series of new reports that provides medical needle free injection market statistics, including medical needle free injection industry global market size, regional shares, competitors with a medical needle free injection market share, detailed medical needle free injection market segments, market trends and opportunities, and any further data you may need to thrive in the medical needle free injection industry. This medical needle free injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical needle-free injection is a device that administers medications or vaccines through the skin using high-pressure technology, eliminating the need for a traditional needle. It works by creating a fine stream of liquid that penetrates the skin, enabling the quick and painless delivery of drugs.
The primary types of medical needle-free injectors include jet-based, spring-based, laser-powered, and vibration-based injectors. Jet-based needle-free injectors use a high-pressure liquid stream to deliver medication through the skin without needles, offering a safer and less painful alternative for administering vaccines and insulin. These injectors can deliver medication in different modes, such as subcutaneous, intramuscular, intradermal (ID), and intravenous (IV), and are used for a variety of applications including vaccine administration, insulin delivery, pain management, oncology treatments, and more. They are utilized by various end-users, including hospitals, clinics, home care settings, research laboratories, and others.
The medical needle-free injection market consists of sales of gas-powered needle-free injectors, electroporation-based injectors, transdermal patch systems, and powder injector systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Needle Free Injection Market Characteristics
3. Medical Needle Free Injection Market Supply Chain Analysis
4. Global Medical Needle Free Injection Market Trends and Strategies
5. Medical Needle Free Injection Market Analysis of End Use Industries
7. Global Medical Needle Free Injection Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Needle Free Injection Total Addressable Market (TAM) Analysis for the Market
9. Medical Needle Free Injection Market Segmentation
10. Medical Needle Free Injection Market Regional and Country Analysis
11. Asia-Pacific Medical Needle Free Injection Market
12. China Medical Needle Free Injection Market
13. India Medical Needle Free Injection Market
14. Japan Medical Needle Free Injection Market
15. Australia Medical Needle Free Injection Market
16. Indonesia Medical Needle Free Injection Market
17. South Korea Medical Needle Free Injection Market
18. Taiwan Medical Needle Free Injection Market
19. South East Asia Medical Needle Free Injection Market
20. Western Europe Medical Needle Free Injection Market
21. UK Medical Needle Free Injection Market
22. Germany Medical Needle Free Injection Market
23. France Medical Needle Free Injection Market
24. Italy Medical Needle Free Injection Market
25. Spain Medical Needle Free Injection Market
26. Eastern Europe Medical Needle Free Injection Market
27. Russia Medical Needle Free Injection Market
28. North America Medical Needle Free Injection Market
29. USA Medical Needle Free Injection Market
30. Canada Medical Needle Free Injection Market
31. South America Medical Needle Free Injection Market
32. Brazil Medical Needle Free Injection Market
33. Middle East Medical Needle Free Injection Market
34. Africa Medical Needle Free Injection Market
36. Medical Needle Free Injection Market Competitive Landscape and Company Profiles
37. Medical Needle Free Injection Market Other Major and Innovative Companies
40. Medical Needle Free Injection Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Needle Free Injection Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical needle free injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical needle free injection? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical needle free injection market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Jet-Based Needle Free Injectors; Spring-Based Needle Free Injectors; Laser-Powered Needle Free Injectors; Vibration-Based Needle Free Injectors2) By Mode Of Delivery: Subcutaneous Delivery; Intramuscular Delivery; Intradermal (ID) Delivery; Intravenous (IV) Delivery
3) By Application: Vaccine Delivery; Insulin Delivery; Pain Management; Oncology; Other Applications
4) By End-User: Hospitals; Clinics; Home Care Settings; Research Laboratories; Other End-Users
Subsegments:
1) By Jet-Based Needle Free Injectors: High-Pressure Jet Injectors; Disposable Jet Injectors; Multi-Use Nozzle Jet Injectors; Gas-Powered Jet Injectors; Electronically Controlled Jet Injectors2) By Spring-Based Needle Free Injectors: Manual Spring-Loaded Injectors; Auto-Spring-Loaded Injectors; Single-Dose Spring Injectors; Reusable Spring Injectors
3) By Laser-Powered Needle Free Injectors: Infrared Laser-Based Injectors; Ultraviolet Laser-Based Injectors; Pulsed Laser Systems; Continuous Wave Laser Systems
4) By Vibration-Based Needle Free Injectors: Ultrasonic Vibration Injectors; Piezoelectric-Based Injectors; Electromagnetic Vibration Injectors; Micro-Vibration-Assisted Delivery Systems
Companies Mentioned: PharmaJet Inc.; Portal Instruments Inc.; Medical International Technology Inc. (MIT); NuGen Medical Devices Inc.; Crossject SA; Bioject Medical Technologies Inc.; Antares Pharma Inc.; Ferring Pharmaceuticals; Akra Dermojet; PenJet Corporation; Vaxxas Pty Ltd.; Micron Biomedical Inc.; Injex Pharma AG; Sol‑Millennium Medical Group; LTS Lohmann Therapie‑Systeme; Enable Injections; Comfort‑in; Needle Free India; Glide Pharma; Aijex Pharma; QS Medical Technology; IntegriMedical; NovaXS Biotech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Needle Free Injection market report include:- PharmaJet Inc.
- Portal Instruments Inc.
- Medical International Technology Inc. (MIT)
- NuGen Medical Devices Inc.
- Crossject SA
- Bioject Medical Technologies Inc.
- Antares Pharma Inc.
- Ferring Pharmaceuticals
- Akra Dermojet
- PenJet Corporation
- Vaxxas Pty Ltd.
- Micron Biomedical Inc.
- Injex Pharma AG
- Sol‑Millennium Medical Group
- LTS Lohmann Therapie‑Systeme
- Enable Injections
- Comfort‑in
- Needle Free India
- Glide Pharma
- Aijex Pharma
- QS Medical Technology
- IntegriMedical
- NovaXS Biotech
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 18.19 Billion |
| Forecasted Market Value ( USD | $ 29.21 Billion |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
